Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Melanoma Research
|
December 4, 2004
Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient
Edit Kovalcsik, Justin John, Matthew Turner, et al.
Medicine
|
December 17, 2017
Case report on the role of radiofrequency-assisted spleen-preserving surgery for splenic metastasis in the era of check-point inhibitors
Satwinder Mudan, Jayant Kumar, Neves C Mafalda, et al.
Cancer Immunology, Immunotherapy : CII
|
July 22, 2008
A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacy
Caroline Schroten-Loef, Corrina M A de Ridder, Suzanne Reneman, et al.
Cancer Immunology, Immunotherapy : CII
|
May 10, 2011
Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2'-Deoxycytidine
Mengyong Yan, Nourredine Himoudi, B Piku Basu, et al.
AIDS Research and Human Retroviruses
|
January 5, 2017
Correlation of Antibody Responses to a Peptide Antigen gp120-C5<sup>501-512</sup>/gp41<sup>732-744</sup> with HIV Disease Progression
Birger Sørensen, Maja A Sommerfelt, Grete Stjernholm, et al.
Annals of Surgical Oncology
|
October 12, 2017
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases
Mark B Faries, Nicola Mozzillo, Mohammed Kashani-Sabet, et al.
Melanoma Research
|
July 31, 2015
Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients
Saif S Ahmad, Wendi Qian, Sarah Ellis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P G Corrie, A Marshall, P D Nathan, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Melanoma Research
|
December 4, 2004
Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient
Edit Kovalcsik, Justin John, Matthew Turner, et al.
Medicine
|
December 17, 2017
Case report on the role of radiofrequency-assisted spleen-preserving surgery for splenic metastasis in the era of check-point inhibitors
Satwinder Mudan, Jayant Kumar, Neves C Mafalda, et al.
Cancer Immunology, Immunotherapy : CII
|
July 22, 2008
A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacy
Caroline Schroten-Loef, Corrina M A de Ridder, Suzanne Reneman, et al.
Cancer Immunology, Immunotherapy : CII
|
May 10, 2011
Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2'-Deoxycytidine
Mengyong Yan, Nourredine Himoudi, B Piku Basu, et al.
AIDS Research and Human Retroviruses
|
January 5, 2017
Correlation of Antibody Responses to a Peptide Antigen gp120-C5<sup>501-512</sup>/gp41<sup>732-744</sup> with HIV Disease Progression
Birger Sørensen, Maja A Sommerfelt, Grete Stjernholm, et al.
Annals of Surgical Oncology
|
October 12, 2017
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases
Mark B Faries, Nicola Mozzillo, Mohammed Kashani-Sabet, et al.
Melanoma Research
|
July 31, 2015
Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients
Saif S Ahmad, Wendi Qian, Sarah Ellis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P G Corrie, A Marshall, P D Nathan, et al.
Page
of 5